Sutro Biopharma names new vice presidents of Clinical Operations and Preclinical Development
17 September 2021 -

Sutro Biopharma, Inc. (NASDAQ: STRO), a clinical-stage pharmaceuticals company, announced on Thursday that it has named Nicole M Chieffo, MBA, as its new Vice President of Clinical Operations and Werner Rubas, PhD as its new Vice President of Preclinical Development.

Chieffo has more than 25 years of clinical operations and development experience. She has served as Sr Director, Oncology Global Operations Head and Lead Oncology Clinical Scientist at Janssen Pharmaceuticals, amongst others.

Dr Rubas has 30 years of experience in the biotech and pharmaceutical industry, including at Nektar Therapeutics for over nine years and as the associate director of the Drug Metabolism and Pharmacokinetics group at Roche in Palo Alto.